Pfizer on Wednesday said its COVID-19 vaccine was 95 percent effective and had no serious side effects — and that it will be submitted for regulatory approval “within days,” according to reports.
The US drugmaker and its German partner BioNTech announced that their vaccine is even more effective at preventing the disease than what they previously thought — 90 percent — last week, NBC News reported.
After completing their Phase 3 trial, the companies said there have been no serious side effects among the 41,135 adults who received two doses. The most common reactions were that 3.7 percent of them experienced fatigue and 2 percent had a headache, they said.
“The study results mark an important step in this historic eight-month journey to bring forward a vaccine capable of helping to end this devastating pandemic,” Pfizer CEO Dr. Albert Bourla said in the statement, NBC News reported.
“With hundreds of thousands of people around the globe infected every day,